Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

Fishing & Farming

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
26.4 CNY -0.86% Intraday chart for Fujian Wanchen Biotechnology Group Co., Ltd. -1.97% -29.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Fujian Wanchen Biotechnology Co., Ltd are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI
Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd Announces Management Appointments CI
Fujian Wanchen Biotechnology Co., Ltd has Changed its Name to Fujian Wanchen Biotechnology Group Co., Ltd CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd announced that it expects to receive CNY 200 million in funding CI
Nanjing Wanpin Commercial Management Co., Ltd. announced that it expects to receive CNY 7 million in funding from Fujian Wanchen Biotechnology Co., Ltd, Huainan Shengyu Enterprise Management Co., Ltd, Huainan Huixiang Enterprise Management Co., Ltd., Xinghua Dewen Management Consulting Co., Ltd., Xinghua Geometry Management Consulting Co., Ltd., and other investors CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 06 June 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Announces Dividend for 2021 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Proposes Final Cash Dividend for 2021 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Fujian Wanchen Biotechnology : Edible Fungus Maker Wanchen Biotechnology to List Nearly 1.3% Stake Post IPO Lockup MT
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Fujian Wanchen Biotechnology Group Co., Ltd.
More charts
Fujian Wanchen Biotechnology Group Co Ltd, formerly Fujian Wanchen Biotechnology Co Ltd, is a China-based company mainly engaged in the research and development, factory cultivation and sales of fresh edible fungi. The Company's edible fungi products include enoki mushrooms and real shimeji mushrooms such as crab-flavored mushrooms, white jade mushroom and seafood mushrooms. The Company also distributes bacteria residue. The Company mainly distributes its products within domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.4 CNY
Average target price
28.67 CNY
Spread / Average Target
+8.60%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300972 Stock
  4. News Fujian Wanchen Biotechnology Group Co., Ltd.
  5. Fujian Wanchen Biotechnology : Edible Fungus Maker Wanchen Biotechnology to List Nearly 1.3% Stake Post IPO Lockup